↑ Grab this Headline Animator

E Med Future EMDFBB Receives Largest Order in Company History

December 29, 2004 -- E Med Future, Inc. (OTCBB: http://finance.yahoo.com/qs=EMDF.OB [EMDF]) has received a five million dollar ($5,000,000) purchase order for NeedleZap, a device that disintegrates used injection needles, from the International Africa AIDS Foundation, said Dane Donohue, Executive Vice President.



According to Donohue, Ray Bailey, Chairman of The International Africa AIDS Foundation, a private foundation, plans to distribute NeedleZap units throughout the 54 African countries during the first half of 2005. The terms of the purchase order require the Foundation to prepay for all NeedleZap units prior to shipment.



"We are pleased that The International Africa AIDS Foundation has included NeedleZap as part of their effort to focus on eliminating the re-use of contaminated needles as a way to help curtail the spread of HIV/AIDS on the African continent," said Donohue. A recent report released by the United Nations estimates that 25.4 million people in sub-Saharan Africa are infected with HIV, an increase of 1 million from the 2003 report.



NeedleZap is currently being used in hospitals and clinics in the African countries of Uganda and Ghana. In addition, dignitaries and Ambassadors from more than 20 African nations attended a formal introduction of NeedleZap in Washington, D.C. last month.



For more information about E Med Future or NeedleZap, call 877-855-1319 or visit www.needlezap.com.



Statements that describe E Med's future plans, objectives or goals are forward-looking statements. These forward-looking statements can generally be identified as such because the context of the statement will include words such as E Med "expects,"anticipates" or words of similar import. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of E Med, as appropriate, and market valuations of their stock, which could cause actual results to differ materially from those currently anticipated. Please refer to E Med's 10-K, 10-Qs and other filings with the SEC for a description of other factors that could cause actual results to differ from those anticipated.



Contact:

E Med Future, Inc.

Don Sullivan, 877-855-1319

e-mail protected from spam bots

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Goodies | Math Goodies | self paced learning |

---

4931 readers online...

, Local News